163 related articles for article (PubMed ID: 29024247)
41. CacyBP/SIP phosphatase activity in neuroblastoma NB2a and colon cancer HCT116 cells.
Kilanczyk E; Wasik U; Filipek A
Biochem Cell Biol; 2012 Aug; 90(4):558-64. PubMed ID: 22480271
[TBL] [Abstract][Full Text] [Related]
42. Structural analysis of Siah1 and its interactions with Siah-interacting protein (SIP).
Matsuzawa S; Li C; Ni CZ; Takayama S; Reed JC; Ely KR
J Biol Chem; 2003 Jan; 278(3):1837-40. PubMed ID: 12421809
[TBL] [Abstract][Full Text] [Related]
43. Distinct effect of CacyBP/SIP on the ERK1/2-CREB-BDNF pathway in undifferentiated and differentiated neuroblastoma NB2a cells.
Rosińska S; Leśniak W; Filipek A
Neurochem Int; 2016 Jul; 97():65-72. PubMed ID: 27180052
[TBL] [Abstract][Full Text] [Related]
44. CacyBP/SIP interacts with tubulin in neuroblastoma NB2a cells and induces formation of globular tubulin assemblies.
Schneider G; Nieznanski K; Kilanczyk E; Bieganowski P; Kuznicki J; Filipek A
Biochim Biophys Acta; 2007 Nov; 1773(11):1628-36. PubMed ID: 17916393
[TBL] [Abstract][Full Text] [Related]
45. Newcastle Disease Virus V Protein Inhibits Cell Apoptosis and Promotes Viral Replication by Targeting CacyBP/SIP.
Chu Z; Wang C; Tang Q; Shi X; Gao X; Ma J; Lu K; Han Q; Jia Y; Wang X; Adam FEA; Liu H; Xiao S; Wang X; Yang Z
Front Cell Infect Microbiol; 2018; 8():304. PubMed ID: 30234028
[TBL] [Abstract][Full Text] [Related]
46. CacyBP/SIP binds ERK1/2 and affects transcriptional activity of Elk-1.
Kilanczyk E; Filipek S; Jastrzebska B; Filipek A
Biochem Biophys Res Commun; 2009 Feb; 380(1):54-9. PubMed ID: 19166809
[TBL] [Abstract][Full Text] [Related]
47. Structural analysis of Siah1-Siah-interacting protein interactions and insights into the assembly of an E3 ligase multiprotein complex.
Santelli E; Leone M; Li C; Fukushima T; Preece NE; Olson AJ; Ely KR; Reed JC; Pellecchia M; Liddington RC; Matsuzawa S
J Biol Chem; 2005 Oct; 280(40):34278-87. PubMed ID: 16085652
[TBL] [Abstract][Full Text] [Related]
48. Bioinformatic analysis of Cacybp-associated proteins using human glioma databases.
Xuan C; Gao Y; Jin M; Xu S; Wang L; Wang Y; Han R; Shi K; Chen X; An Q
IUBMB Life; 2019 Jul; 71(7):827-834. PubMed ID: 30762928
[TBL] [Abstract][Full Text] [Related]
49. CacyBP/SIP expression is involved in the clinical progression of breast cancer.
Wang N; Ma Q; Wang Y; Ma G; Zhai H
World J Surg; 2010 Nov; 34(11):2545-52. PubMed ID: 20585948
[TBL] [Abstract][Full Text] [Related]
50. S100A6 and CacyBP/SIP - two proteins discovered in ehrlich ascites tumor cells that are potentially involved in the degradation of beta-catenin.
Filipek A
Chemotherapy; 2006; 52(1):32-4. PubMed ID: 16340196
[TBL] [Abstract][Full Text] [Related]
51. The role of p27(Kip1) phosphorylation at serine 10 in the migration of malignant glioma cells in vitro.
Wang D; He F; Zhang L; Zhang F; Wang Q; Qian X; Pan X; Meng J; Peng C; Shen A; Chen J
Neoplasma; 2011; 58(1):65-73. PubMed ID: 21067268
[TBL] [Abstract][Full Text] [Related]
52. NEDD4-1 regulates migration and invasion of glioma cells through CNrasGEF ubiquitination in vitro.
Zhang H; Nie W; Zhang X; Zhang G; Li Z; Wu H; Shi Q; Chen Y; Ding Z; Zhou X; Yu R
PLoS One; 2013; 8(12):e82789. PubMed ID: 24340059
[TBL] [Abstract][Full Text] [Related]
53. Regulation of CacyBP/SIP expression by NFAT1 transcription factor.
Kądziołka B; Leśniak W; Filipek A
Immunobiology; 2017 Aug; 222(8-9):872-877. PubMed ID: 28526484
[TBL] [Abstract][Full Text] [Related]
54. Calcyclin-binding protein contributes to cholangiocarcinoma progression by inhibiting ubiquitination of MCM2.
Zhang Y; Liu L; Luo B; Tang H; Yu X; Bao S
Oncol Res; 2023; 31(3):317-331. PubMed ID: 37305391
[TBL] [Abstract][Full Text] [Related]
55. Regulation of glioma migration and invasion via modification of Rap2a activity by the ubiquitin ligase Nedd4-1.
Wang L; Zhu B; Wang S; Wu Y; Zhan W; Xie S; Shi H; Yu R
Oncol Rep; 2017 May; 37(5):2565-2574. PubMed ID: 28405688
[TBL] [Abstract][Full Text] [Related]
56. Involvement of two distinct ubiquitin E3 ligase systems for p27 degradation in corneal endothelial cells.
Lee JG; Kay EP
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):189-96. PubMed ID: 18172092
[TBL] [Abstract][Full Text] [Related]
57. CacyBP/SIP promotes tumor progression by regulating apoptosis and arresting the cell cycle in osteosarcoma.
Zhao M; Zhang RZ; Qi DW; Chen HY; Zhang GC
Exp Ther Med; 2020 Aug; 20(2):1397-1404. PubMed ID: 32742374
[TBL] [Abstract][Full Text] [Related]
58. LIM domain only 2 induces glioma invasion via cytosolic p27(KIP1).
Park CG; Sohn YW; Kim EJ; Kim SH; Kim SC; Kim H
Tumour Biol; 2016 Feb; 37(2):2473-80. PubMed ID: 26383528
[TBL] [Abstract][Full Text] [Related]
59. MAP kinase p38 is a novel target of CacyBP/SIP phosphatase.
Topolska-Woś AM; Rosińska S; Filipek A
Amino Acids; 2017 Jun; 49(6):1069-1076. PubMed ID: 28283909
[TBL] [Abstract][Full Text] [Related]
60. Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase.
Kamura T; Hara T; Matsumoto M; Ishida N; Okumura F; Hatakeyama S; Yoshida M; Nakayama K; Nakayama KI
Nat Cell Biol; 2004 Dec; 6(12):1229-35. PubMed ID: 15531880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
